Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BALTI-2: Beta Agonists in Lung Injury Trial
2006-002647-86Phase 4Terminated
- Sponsor
- Heart of England NHS Foundation Trust
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute respiratory distress syndrome (ARDS) comparing Intravenous Ventolin (salbutamol) with Placebo / standard care (2 arms). Primary endpoints: 28-day all-cause mortality and Ventilator-free days. Started Feb 2008; status: terminated.
02
Drugs
salbutamol
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on 2006-002647-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002647-86.